PCPs estimated that nearly 30% of their patients have requested GLP-1 prescriptions for weight loss
Your healthcare provider will start you on a low dose and gradually increase it based on your body's response
10.2337/db13-1440 106 SakarY.DucaF
Among those taking semaglutide for type 2 diabetes, 8.9 per cent developed NAION, compared to 1.8 per cent taking non-GLP-1 medications, researchers found
It is well-tolerated, extensively studied, and provides a strong foundation before adding more targeted peptides
02Track Food, Water, Protein, and the Weekly Shot in One Place A generic weight loss tracker app usually treats the scale as the main event and everything else as optional